Proteomics and Disease Revisited: The Challenge of Providing Proteomic Tools into Clinical Practice

被引：14

作者：

Fehniger, Thomas E. ^{[1
,2
]}

Marko-Varga, Gyorgy ^{[2
,3
]}

机构：

[1] Tallinn Univ Technol, Inst Clin Med, Tallinn, Estonia

[2] Lund Univ, Biomed Ctr, Clin Prot Sci & Imaging Grp, Lund, Sweden

[3] Tokyo Med Univ, Tokyo, Japan

来源：

JOURNAL OF PROTEOME RESEARCH | 2010年 / 9卷 / 03期

关键词：

D O I：

10.1021/pr1000237

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1191 / 1192

页数：2

共 7 条

[1]

ANDERSON NL, 2010, CLIN CHEM, V56, P1

[2]

Celis JE, 2005, MOL CELL PROTEOMICS, V4, P345

[3] The human disease network [J].

Goh, Kwang-Il ;

Cusick, Michael E. ;

Valle, David ;

Childs, Barton ;

Vidal, Marc ;

Barabasi, Albert-Laszlo .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (21) :8685-8690

[4] Common Genetic Variation and Human Traits [J].

Goldstein, David B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (17) :1696-1698

[5] Genetic Risk Prediction - Are We There Yet? [J].

Kraft, Peter ;

Hunter, David J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (17) :1701-1703

[6] Laboratory reference value [J].

Kratz, A ;

Ferraro, M ;

Sluss, PM ;

Lewandrowski, KB .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) :1548-1563

[7]

MARKOVARGA G, 2004, J PROTEOME RES, V3, P145

← 1 →